LRRK2 parkinsonism in Tunisia and Norway: a comparative analysis of disease penetrance.
about
Efficient Estimation of Nonparametric Genetic Risk Function with Censored Data.Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium.Novel recruitment strategy to enrich for LRRK2 mutation carriersGenetics and genomics of Parkinson's disease.Increased peripheral inflammation in asymptomatic leucine-rich repeat kinase 2 mutation carriers.Exploring cancer in LRRK2 mutation carriers and idiopathic Parkinson's disease.
P2860
LRRK2 parkinsonism in Tunisia and Norway: a comparative analysis of disease penetrance.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
LRRK2 parkinsonism in Tunisia and Norway: a comparative analysis of disease penetrance.
@ast
LRRK2 parkinsonism in Tunisia and Norway: a comparative analysis of disease penetrance.
@en
LRRK2 parkinsonism in Tunisia and Norway: a comparative analysis of disease penetrance.
@nl
type
label
LRRK2 parkinsonism in Tunisia and Norway: a comparative analysis of disease penetrance.
@ast
LRRK2 parkinsonism in Tunisia and Norway: a comparative analysis of disease penetrance.
@en
LRRK2 parkinsonism in Tunisia and Norway: a comparative analysis of disease penetrance.
@nl
prefLabel
LRRK2 parkinsonism in Tunisia and Norway: a comparative analysis of disease penetrance.
@ast
LRRK2 parkinsonism in Tunisia and Norway: a comparative analysis of disease penetrance.
@en
LRRK2 parkinsonism in Tunisia and Norway: a comparative analysis of disease penetrance.
@nl
P2093
P2860
P1433
P1476
LRRK2 parkinsonism in Tunisia and Norway: a comparative analysis of disease penetrance
@en
P2093
Christina Thompson
Ekaterina Nosova
Faycel Hentati
Jan O Aasly
Joanne Trinh
P2860
P304
P356
10.1212/WNL.0000000000000675
P407
P577
2014-07-09T00:00:00Z